122 related articles for article (PubMed ID: 32349558)
1. Different approaches to advanced soft tissue sarcomas depending on treatment line, goal of therapy and histological subtype.
Martín-Broto J; Reichardt P; Jones RL; Stacchiotti S
Expert Rev Anticancer Ther; 2020 Apr; 20(sup1):15-28. PubMed ID: 32349558
[No Abstract] [Full Text] [Related]
2. Establishing biomarkers for soft tissue sarcomas.
Czarnecka AM; Chmiel P; Błoński P; Rutkowski P
Expert Rev Anticancer Ther; 2024 Jun; 24(6):407-421. PubMed ID: 38682679
[TBL] [Abstract][Full Text] [Related]
3. Systemic Therapy in Advanced Pleomorphic Liposarcoma: a Comprehensive Review.
Assi T; Ngo C; Faron M; Verret B; Lévy A; Honoré C; Hénon C; Le Péchoux C; Bahleda R; Le Cesne A
Curr Treat Options Oncol; 2023 Nov; 24(11):1598-1613. PubMed ID: 37843627
[TBL] [Abstract][Full Text] [Related]
4. Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial.
Italiano A; Dinart D; Soubeyran I; Bellera C; Espérou H; Delmas C; Mercier N; Albert S; Poignie L; Boland A; Bourdon A; Geneste D; Cavaille Q; Laizet Y; Khalifa E; Auzanneau C; Squiban B; Truffaux N; Olaso R; Gerber Z; Wallet C; Bénard A; Blay JY; Laurent-Puig P; Deleuze JF; Lucchesi C; Mathoulin-Pelissier S;
BMC Cancer; 2021 Nov; 21(1):1180. PubMed ID: 34740331
[TBL] [Abstract][Full Text] [Related]
5. Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin.
Desar IM; Constantinidou A; Kaal SE; Jones RL; van der Graaf WT
Cancer Manag Res; 2016; 8():95-104. PubMed ID: 27574465
[TBL] [Abstract][Full Text] [Related]
6. Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations.
In GK; Hu JS; Tseng WW
Ther Adv Med Oncol; 2017 Aug; 9(8):533-550. PubMed ID: 28794805
[TBL] [Abstract][Full Text] [Related]
7. Systemic therapy for advanced soft tissue sarcomas: highlighting novel therapies and treatment approaches.
Riedel RF
Cancer; 2012 Mar; 118(6):1474-85. PubMed ID: 21837668
[TBL] [Abstract][Full Text] [Related]
8. UK guidelines for the management of soft tissue sarcomas.
Hayes AJ; Nixon IF; Strauss DC; Seddon BM; Desai A; Benson C; Judson IR; Dangoor A
Br J Cancer; 2024 May; ():. PubMed ID: 38734790
[TBL] [Abstract][Full Text] [Related]
9. Creating a data commons: The INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT).
Wyatt KD; Birz S; Hawkins DS; Minard-Colin V; Rodeberg DA; Sparber-Sauer M; Bisogno G; Koscielniak E; De Salvo GL; Ebinger M; Merks JHM; Wolden SL; Xue W; Volchenboum SL;
Pediatr Blood Cancer; 2022 Nov; 69(11):e29924. PubMed ID: 35969120
[TBL] [Abstract][Full Text] [Related]
10. Evaluating health perceptions of soft-tissue sarcoma patients using the Wilson-Cleary Model to identify key targets for improving outcomes and quality of care.
Andersen NJ; Mate KKB; Bergeron C; Turcotte R; Körner A
Surg Oncol; 2024 Feb; 52():102028. PubMed ID: 38150784
[TBL] [Abstract][Full Text] [Related]
11. Geriatric Assessment of Older Patients Receiving Trabectedin in First-Line Treatment for Advanced Soft Tissue Sarcomas: The E-TRAB Study from The German Interdisciplinary Sarcoma Group (GISG-13).
Kasper B; Pink D; Rothermundt C; Richter S; Augustin M; Kollar A; Kunitz A; Eisterer W; Gaidzik V; Brodowicz T; Egerer G; Reichardt P; Hohenberger P; Schuler MK
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339308
[TBL] [Abstract][Full Text] [Related]
12. New drugs and combinations for the treatment of soft-tissue sarcoma: a review.
Somaiah N; von Mehren M
Cancer Manag Res; 2012; 4():397-411. PubMed ID: 23226072
[TBL] [Abstract][Full Text] [Related]
13. The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma.
Heater NK; Okuno S; Robinson S; Attia S; Seetharam M; Siontis BL; Yoon J; Chawla S; Milhem MM; Monga V; Skubitz K; Charlson J; Hirbe AC; Weiss MC; Van Tine B; Agulnik M
J Clin Med; 2023 Mar; 12(7):. PubMed ID: 37048645
[TBL] [Abstract][Full Text] [Related]
14. Enhancing Healthcare for Sarcoma Patients: Lessons from a Diagnostic Pathway Efficiency Analysis.
Elyes M; Heesen P; Schelling G; Bode-Lesniewska B; Studer G; Fuchs B;
Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835586
[TBL] [Abstract][Full Text] [Related]
15. Soft Tissue Sarcomas: Treatment and Management.
Miwa S; Wu PK; Tsuchiya H
Cancers (Basel); 2024 Mar; 16(5):. PubMed ID: 38473399
[TBL] [Abstract][Full Text] [Related]
16. Afami-cel provides a novel treatment option for rare sarcoma subtypes.
Sidaway P
Nat Rev Clin Oncol; 2024 Jun; 21(6):401. PubMed ID: 38637649
[No Abstract] [Full Text] [Related]
17. Current Reality of Treating Advanced Soft Tissue Sarcoma as Illustrated by Case Studies.
Broto JM; Jones RL
Oncology; 2021; 99 Suppl 1():8-16. PubMed ID: 33849013
[TBL] [Abstract][Full Text] [Related]
18. Real-world evidence of the efficacy and tolerability of trabectedin in patients with advanced soft-tissue sarcoma.
de Sande González LM; Martin-Broto J; Kasper B; Blay JY; Le Cesne A
Expert Rev Anticancer Ther; 2020 Nov; 20(11):957-963. PubMed ID: 32930637
[TBL] [Abstract][Full Text] [Related]
19. The current reality of soft tissue sarcomas: advances, controversies, areas for improvement, and promising new treatments.
Blay JY; Le Cesne A; Demetri GD
Expert Rev Anticancer Ther; 2020 Apr; 20(sup1):29-39. PubMed ID: 32349562
[No Abstract] [Full Text] [Related]
20. Early phase trials in soft-tissue sarcomas: clinical benefit of inclusion in early lines of treatment, molecular screening, and histology-driven trials.
Nassif EF; Blay JY; Massard C; Dufresne A; Brahmi M; Cassier P; Ray-Coquard I; Pautier P; Leary A; Sunyach MP; Bahleda R; Levy A; Le Pechoux C; Honoré C; Mir O; Le Cesne A
ESMO Open; 2022 Apr; 7(2):100425. PubMed ID: 35255445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
